Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Flores-Suárez, L. F.
Right arrow Articles by Alcocer-Varela, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flores-Suárez, L. F.
Right arrow Articles by Alcocer-Varela, J.
Related Collections
Right arrow Systemic Lupus Erythematosus and Autoimmunity
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2003; 42: 223-229
© 2003 British Society for Rheumatology

Prevalence of antineutrophil cytoplasmic autoantibodies in patients with tuberculosis

L. F. Flores-Suárez1,, J. Cabiedes1, A. R. Villa2, F. J. van der Woude3 and J. Alcocer-Varela1

1 Department of Immunology and Rheumatology and
2 Clinical Epidemiology Unit, Instituto Nacional de Ciencias Médicas y Nutrición, México City, México and
3 Medical Clinic V, Faculty of Clinical Medicine Mannheim, Ruperto Carola University, Heildelberg, Germany

Objective. To determine the prevalence of antineutrophil cytoplasmic autoantibodies (ANCA) in sera of patients with tuberculosis compared with healthy control subjects and a group of patients with atopic asthma.

Methods. The presence of ANCA was examined in patients with tuberculosis, and in asthmatic patients and healthy subjects as control groups, by means of indirect immunofluorescence (IIF) and enzyme-linked immunosorbent assay (ELISA) to detect anti-proteinase 3 (PR3-ANCA) and antimyeloperoxidase (MPO-ANCA) antibodies.

Results. ANCA were present in 20 (44.4%) of 45 tuberculosis patients by IIF (16 c-ANCA, four p-ANCA) and in 18 (40%) patients by ELISA (15 PR3-ANCA, three MPO-ANCA). High odds ratios for ANCA positivity were observed for tuberculosis patients when compared with both control groups. ANCA results were not related to the category of tuberculosis, stage of disease, presence of concomitant diseases or pharmacotherapy.

Conclusions. As many clinical similarities between tuberculosis and Wegener's granulomatosis exist, we propose that a positive ANCA test in patients living in countries with a high prevalence of tuberculosis must be carefully interpreted as indicative of systemic vasculitis, especially when no signs of extrapulmonary involvement occur.

KEY WORDS: Antineutrophil cytoplasm autoantibodies, Tuberculosis.

Correspondence to: L. F. Flores-Suárez, Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición, Vasco de Quiroga 15, Col. Sección XVI, Tlalpan, C.P. 14000, México, DF, México. E-mail: felipe98{at}prodigy.net.mx


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CVIHome page
L. A. Sechi, V. Rosu, A. Pacifico, G. Fadda, N. Ahmed, and S. Zanetti
Humoral Immune Responses of Type 1 Diabetes Patients to Mycobacterium avium subsp. paratuberculosis Lend Support to the Infectious Trigger Hypothesis
Clin. Vaccine Immunol., February 1, 2008; 15(2): 320 - 326.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
L. Teixeira, A. Mahr, F. Jaureguy, L.-H. Noel, H. Nunes, A. Lefort, S. Barry, P. Deny, and L. Guillevin
Low seroprevalence and poor specificity of antineutrophil cytoplasmic antibodies in tuberculosis
Rheumatology, February 1, 2005; 44(2): 247 - 250.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.